TCR2 THERAPEUTICS INC. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q2 2021 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payment for operating lease.
-
Summary
-
Tcr2 Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2021 to Q1 2023.
- Tcr2 Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending March 31, 2023 was $6.66M, a 93.2% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)